Anarthria clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
open to eligible people ages 18-80
The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.
at UC Davis
Our lead scientists for Anarthria research studies include Sergey Stavisky, Ph.D..
Last updated: